Home » Topics » Briefs » Other news to note

Other news to note
RSS

GHIT Fund secures over USD 200 million in commitments for second phase replenishment

June 2, 2017

Ligand Pharmaceuticals enters agreement with xCella Biosciences

May 31, 2017

i2 Pharmaceuticals acquires antibody and protein therapeutics portfolio

May 31, 2017

Inspyr Therapeutics to merge with Lewis and Clark Pharmaceuticals to create novel integrated company

May 31, 2017

GlaxoSmithKline initiates enrollment in first-in-human study of GSK-3352589

May 26, 2017

HitGen forms drug discovery collaboration with Scripps Research Institute and Calibr

May 25, 2017

Corbin Therapeutics and Proteorex Therapeutics enter research and development collaboration

May 22, 2017

Otsuka Pharmaceutical recaps highlights of first quarter 2017

May 18, 2017

Takeda announces further details of partnership with Bushu Pharmaceuticals

May 17, 2017

Astellas completes Ogeda acquisition

May 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...